(Q43777233)

26 November 2017

title

E7070, a novel sulphonamide agent with potent antitumour activity in vitro and in vivo (English)

1 reference

26 November 2017

Ozawa Y

1

1 reference

26 November 2017

Sugi NH

2

1 reference

26 November 2017

Nagasu T

3

1 reference

26 November 2017

Owa T

4

1 reference

26 November 2017

Watanabe T

5

1 reference

26 November 2017

Koyanagi N

6

1 reference

26 November 2017

Yoshino H

7

1 reference

26 November 2017

Kitoh K

8

1 reference

26 November 2017

Yoshimatsu K

9

1 reference

26 November 2017

publication date

1 November 2001

1 reference

European Journal of Cancer

26 November 2017

published in

1 reference

26 November 2017

volume

37

1 reference

26 November 2017

issue

17

1 reference

26 November 2017

page(s)

2275-2282

1 reference

Novel sulfonamides as potential, systemically active antitumor agents

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900275-1

7 January 2021

Phase I study of E7010

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900275-1

7 January 2021

A focused compound library of novel N-(7-indolyl)benzenesulfonamides for the discovery of potent cell cycle inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900275-1

7 January 2021

Discovery of novel antitumor sulfonamides targeting G1 phase of the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900275-1

7 January 2021

G1 phase progression: cycling on cue

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900275-1

7 January 2021

Cell cycle regulation and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900275-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900275-1

1 reference

7 January 2021

Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell-cycle distribution of human epidermoid carcinoma, A431 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900275-1

7 January 2021

Inhibition of c-myc gene expression in murine lymphoblastoma cells by geldanamycin and herbimycin, antibiotics of benzoquinoid ansamycin group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900275-1

7 January 2021

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900275-1

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900275-1

7 January 2021

Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900275-1

7 January 2021

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900275-1

7 January 2021

CPT-11 in gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900275-1

7 January 2021

Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900275-1

7 January 2021

Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900275-1

7 January 2021

Biological characterization and oncogene expression in human colorectal carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900275-1

7 January 2021

10.1016/S0959-8049(01)00275-1

Identifiers

DOI

1 reference

26 November 2017

1 reference